Biomea Fusion (BMEA) News Today

Truist Financial lowered Biomea Fusion from a "buy" rating to a "hold" rating in a research report on Tuesday.

Citigroup decreased their target price on shares of Biomea Fusion from $90.00 to $45.00 and set a "buy" rating on the stock in a research report on Friday.

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 13,140,000 shares, a drop of 5.9% from the April 30th total of 13,970,000 shares. Based on an average daily trading volume, of 990,500 shares, the short-interest ratio is presently 13.3 days. Approximately 47.2% of the company's shares are short sold.

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven research firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and five have given a buy rating t

Oppenheimer lowered their price objective on Biomea Fusion from $70.00 to $60.00 and set an "outperform" rating on the stock in a research report on Thursday.

HC Wainwright reaffirmed a "buy" rating and issued a $50.00 target price on shares of Biomea Fusion in a research report on Friday.

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 13,240,000 shares, an increase of 18.2% from the March 15th total of 11,200,000 shares. Currently, 47.8% of the company's stock are short sold. Based on an average daily trading volume, of 1,020,000 shares, the short-interest ratio is currently 13.0 days.

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have received an average rating of "Moderate Buy" from the eight research firms that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and six have issued a buy re

Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2024 earnings estimates for shares of Biomea Fusion in a report released on Monday, April 1st. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings per share

Oppenheimer restated an "outperform" rating and issued a $70.00 price objective on shares of Biomea Fusion in a report on Wednesday.

Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Analysts at HC Wainwright issued their Q3 2024 earnings estimates for Biomea Fusion in a report issued on Monday, April 1st. HC Wainwright analyst J. Pantginis forecasts that the company will post earnings per share of ($1.06) for the quarter. HC

JPMorgan Chase & Co. reissued a "neutral" rating and issued a $14.00 target price (down from $51.00) on shares of Biomea Fusion in a report on Tuesday.

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 11,200,000 shares, an increase of 6.9% from the February 29th total of 10,480,000 shares. Currently, 40.6% of the company's shares are sold short. Based on an average daily volume of 976,000 shares, the short-interest ratio is presently 11.5 days.

Biomea Fusion (NASDAQ:BMEA) Trading Up 7.2%

Biomea Fusion (NASDAQ:BMEA) Stock Price Down 5.9%

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a large drop in short interest in the month of February. As of February 29th, there was short interest totalling 10,480,000 shares, a drop of 11.0% from the February 14th total of 11,780,000 shares. Based on an average daily trading volume, of 1,250,000 shares, the days-to-cover ratio is currently 8.4 days. Currently, 38.0% of the company's shares are sold short.

Biomea Fusion (NASDAQ:BMEA) Trading 6.7% Higher

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock investors bought 32,261 call options on the stock. This is an increase of 903% compared to the average daily volume of 3,217 call options.

Adage Capital Partners GP L.L.C. raised its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 125.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 180,000 shares of the company's stock